Differentiation-coupled induction of human cytomegalovirus replication by union of the major enhancer retinoic acid, cyclic AMP, and NF-κB response elements

Journal of Virology

Volumn 89, Issue 24, 2015, Pages 12284-12298

  Yuan, Jinxiang ^b   Li, Ming ^b   Torres, Yasaira Rodriguez ^b   Galle, Courtney S ^b   Meier, Jeffery L ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; CYCLIC AMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL ESTER; RETINOIC ACID; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR ELK 1; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; CYTOMEGALOVIRUS INFECTION; DNA RESPONSIVE ELEMENT; ENHANCER REGION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; NONHUMAN; PRIORITY JOURNAL; SERUM RESPONSIVE ELEMENT; VIRUS INDUCTION; VIRUS REPLICATION; CYTOMEGALOVIRUS; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CYCLIC AMP; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; NF-KAPPA B; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TRETINOIN; VIRUS REPLICATION;

EID: 84949908366     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00965-15     Document Type: Article

References (60)

1. Cohen JI. 2010. Introduction to Herpesviridae, p 1937-1942. In Mandell GL, Bennett JE, Dolin R (ed), Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Churchill Livingston Elsevier, Philadelphia, PA.
2. Crumpacker CS, Zhang JL. 2010. Cytomegalovirus, p 1971-1987. In Mandell GL, Bennett JE, Dolin R (ed), Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Churchill Livingston Elsevier, Philadelphia, PA.
3. Lisco A, Munawwar A, Introini A, Vanpouille C, Saba E, Feng X, Grivel JC, Singh S, Margolis L. 2012. Semen of HIV-1-infected individuals: local shedding of herpesviruses and reprogrammed cytokine network. J Infect Dis 205:97-105. http://dx.doi.org/10.1093/infdis/jir700.
4. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR, Allen U, Humar A, Transplantation Society International CMV Consensus Group. 2010. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 89:779-795. http://dx.doi.org/10.1097/TP.0b013e3181cee42f.
5. Jacobson M, Lurain N, Hunt P. 2011. Cytomegalovirus viraemia in the modern antiretroviral era. HIV Med 12:387-388. http://dx.doi.org/10.1111/j.1468-1293.2010.00899.x.
6. Simon CO, Seckert CK, Reddehase MJ, Grzimek NKA. 2006. Murine model of cytomegalovirus latency and reactivation: the silencing/desilencing and immune sensing hypothesis, p 483-500. In Reddehase MJ (ed), Cytomegaloviruses: molecular biology and immunology. Caister Academic Press, Norfolk, United Kingdom.
7. Boeckh M, Geballe AP. 2011. Cytomegalovirus: pathogen, paradigm, and puzzle. J Clin Invest 121:1673-1680. http://dx.doi.org/10.1172/JCI45449.
8. Tsutsui Y, Kawasaki H, Kosugi I. 2002. Reactivation of latent cytomegalovirus infection in mouse brain cells detected after transfer to brain slice cultures. J Virol 76:7247-7254. http://dx.doi.org/10.1128/JVI.76.14.7247-7254.2002.
9. Arribas JR, Storch GA, Clifford DB, Tselis AC. 1996. Cytomegalovirus encephalitis. Ann Intern Med 125:577-587. http://dx.doi.org/10.7326/0003-4819-125-7-199610010-00008.
10. Wiley CA, Schrier RD, Denaro FJ, Nelson JA, Lampert PW, Oldstone MB. 1986. Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient. J Neuropathol Exp Neurol 45:127-139. http://dx.doi.org/10.1097/00005072-198603000-00003.
11. Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, Dracopoli NC, Fogh J. 1984. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest 50:147-162.
12. Meier JL. 2001. Reactivation of the human cytomegalovirus major immediate-early regulatory region and viral replication in embryonal NTera2 cells: role of trichostatin A, retinoic acid, and deletion of the 21-base-pair repeats and modulator. J Virol 75:1581-1593. http://dx.doi.org/10.1128/JVI.75.4.1581-1593.2001.
13. Gonczol E, Andrews PW, Plotkin SA. 1984. Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells. Science 224:159-161. http://dx.doi.org/10.1126/science.6322309.
14. Meier JL, Stinski MF. 1997. Effect of a modulator deletion on transcription of the human cytomegalovirus major immediate-early genes in infected undifferentiated and differentiated cells. J Virol 71:1246-1255.
15. Bani-Yaghoub M, Felker JM, Naus CG. 1999. Human NT2/D1 cells differentiate into functional astrocytes. Neuroreport 10:3843-3846. http://dx.doi.org/10.1097/00001756-199912160-00022.
16. Andrews PW. 1984. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev Biol 103:285-293.http://dx.doi.org/10.1016/0012-1606(84)90316-6.
17. Angulo A, Suto C, Boehm MF, Heyman RA, Ghazal P. 1995. Retinoid activation of retinoic acid receptors but not of retinoid X receptors pro-motes cellular differentiation and replication of human cytomegalovirus in embryonal cells. J Virol 69:3831-3837.
18. Sinclair J, Sissons P. 2006. Latency and reactivation of human cytomegalovirus. J Gen Virol 87:1763-1779. http://dx.doi.org/10.1099/vir.0.81891-0.
19. Reeves MB, Sinclair JH. 2010. Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter. J Gen Virol 91:599-604. http://dx.doi.org/10.1099/vir.0.015602-0.
20. Penkert RR, Kaletja RF. 2013. Human embryonic stem cell lines model experimental human cytomegalovirus latency. mBio 4:e00298-13. http://dx.doi.org/10.1128/mBio.00298-13.
21. Belzile J-P, Stark TJ, Yeo GW, Spector DH. 2014. Human cytomegalovirus infection of human embryonic stem cell-derived primitive neural stem cells is restricted at several steps but leads to the persistence of viral DNA. J Virol 88:4021-4039. http://dx.doi.org/10.1128/JVI.03492-13.
22. Yuan J, Liu X, Wu AW, McGonagill PW, Keller MJ, Galle CS, Meier JL. 2009. Breaking human cytomegalovirus major immediate-early gene silence by vasoactive intestinal peptide stimulation of the protein kinase A-CREB-TORC2 signaling cascade in human pluripotent embryonal NTera2 cells. J Virol 83:6391-6401. http://dx.doi.org/10.1128/JVI.00061-09.
23. Liu X, Yuan J, Wu AW, McGonagill PW, Galle CS, Meier JL. 2010. Phorbol ester-induced human cytomegalovirus MIE enhancer activation through PKC-delta, CREB, and NF-κB de-silences MIE gene expression in quiescently infected human pluripotent NTera2 cells. J Virol 84:8495-8508.http://dx.doi.org/10.1128/JVI.00416-10.
24. O'Connor CM, Murphy EA. 2012. A myeloid progenitor cell line capable of supporting human cytomegalovirus latency and reactivation, resulting in infectious progeny. J Virol 86:9854-9865. http://dx.doi.org/10.1128/JVI.01278-12.
25. Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, Jones SB, Brooks JD, Andrews PW, Brown PO, Thomson JA. 2003. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci U S A 100:13350-13355. http://dx.doi.org/10.1073/pnas.2235735100.
26. Liu Y, Shin S, Zeng X, Zhan M, Gonzalez R, Mueller FJ, Schwartz CM, Xue H, Li H, Baker SC, Chudin E, Barker DL, McDaniel TK, Oeser S, Loring JF, Mattson MP, Rao MS. 2006. Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. BMC Dev Biol 6:20.
27. Josephson R, Ording CJ, Liu Y, Shin S, Lakshmipathy U, Toumadje A, Love B, Chesnut JD, Andrews PW, Rao MS, Auerbach JM. 2007. Qualification of embryonal carcinoma 2102Ep as a reference for human embryonic stem cell research. Stem Cells 25:437-446. http://dx.doi.org/10.1634/stemcells.2006-0236.
28. Matin MM, Walsh JR, Gokhale PJ, Draper JS, Morton ARBI, Moore HD, Andrews PW. 2004. Specific knockdown of Oct4 and B2-microglobulin expression by RNA interference in human embryonic stem cells. Stem Cells 22:659-668. http://dx.doi.org/10.1634/stemcells.22-5-659.
29. Greber B, Lehrach H, Adjaye J. 2007. Silencing of core transcription factors in human EC cells highlights the importance of autocrine FGF signaling for self-renewal. BMC Dev Biol 7:46. http://dx.doi.org/10.1186/1471-213X-7-46.
30. Lundquist CA, Meier JL, Stinski MF. 1999. A strong transcriptional negative regulatory region between the human cytomegalovirus UL127 gene and the major immediate early enhancer. J Virol 73:9039-9052.
31. Dunn W, Chou C, Li H, Hai R, Patterson D, Stoic V, Zhu H, Liu F. 2003. Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A 100:14223-14228. http://dx.doi.org/10.1073/pnas.2334032100.
32. Angulo A, Suto C, Heymen RA, Ghazal P. 1996. Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids. Mol Endocrinol 10:781-793.
33. Caposio P, Luganini A, Bronzini M, Landolfo S, Gribaudo G. 2010. The Elk-1 and serum response factor binding sites in the major immediateearly promoter of the human cytomegalovirus are required for efficient viral replication in quiescent cells and compensate for inactivation of the NF-{kappa}B sites in proliferating cells. J Virol 84:4481-4493. http://dx.doi.org/10.1128/JVI.02141-09.
34. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction. Anal Biochem 162:156-159.
35. Meier JL, Keller MJ, McCoy JJ. 2002. Requirement of multiple cis-acting elements in the human cytomegalovirus major immediate-early distal enhancer for activation of viral gene expression and replication. J Virol 76: 313-320. http://dx.doi.org/10.1128/JVI.76.1.313-326.2002.
36. White EA, Clark CL, Sanchez V, Spector DH. 2004. Small internal deletions in the human cytomegalovirus IE2 gene result in nonviable recombinant viruses with differential defects in viral gene expression. J Virol 78:1817-1830. http://dx.doi.org/10.1128/JVI.78.4.1817-1830.2004.
37. White EA, Del Rosario CJ, Sanders RL, Spector DH. 2007. The IE2 60-kilodalton and 40-kilodalton proteins are dispensable for human cytomegalovirus replication but are required for efficient delayed early and late gene expression and production of infectious virus. J Virol 81:2573-2583.http://dx.doi.org/10.1128/JVI.02454-06.
38. Ghazal P, DeMattei C, Giulietti E, Kliewer SA, Umesono K, Evans RM. 1992. Retinoic acid receptors initiate induction of the cytomegalovirus enhancer in embryonal cells. Proc Natl Acad Sci U S A 89:7630-7634. http://dx.doi.org/10.1073/pnas.89.16.7630.
39. O'Connor CM, Vanicek J, Murphy EA. 2014. Host microRNA regulation of human cytomegalovirus immediate early protein translation promotes viral latency. J Virol 88:5524-5532. http://dx.doi.org/10.1128/JVI.00481-14.
40. Saffert RT, Kalejta RF. 2006. Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J Virol 80:3863-3873. http://dx.doi.org/10.1128/JVI.80.8.3863-3871.2006.
41. Teng MW, Bolovan-Fritts C, Dar RD, Womack A, Simpson ML, Shenk T, Weinberger LS. 2012. An endogenous accelerator for viral gene expression confers a fitness advantage. Cell 151:1569-1580. http://dx.doi.org/10.1016/j.cell.2012.11.051.
42. Meier JL, Stinski MF. 2013. Major immediate-early enhancer and its gene products, p 151-166. In Reddehase MJ (ed), Cytomegaloviruses: from molecular pathogenesis to intervention, vol 1. Caister Academic Press/Horizon, Norfolk, United Kingdom.
43. Keller MJ, Wheeler DG, Cooper E, Meier JL. 2003. Role of the human cytomegalovirus major immediate-early promoter's 19-base-pair-repeat cAMP-response element in acutely infected cells. J Virol 77:6666-6675. http://dx.doi.org/10.1128/JVI.77.12.6666-6675.2003.
44. Isern E, Gustems M, Messerle M, Borst E, Ghazal P, Angulo A. 2011. The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-{kappa}B sites during acute infection. J Virol 85:1732-1746. http://dx.doi.org/10.1128/JVI.01713-10.
45. Caposio P, Luganini A, Hahn G, Landolfo S, Gribaudo G. 2007. Activation of the virus-induced IKK/NF-kappaB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells. Cell Microbiol 9:2040-2054. http://dx.doi.org/10.1111/j.1462-5822.2007.00936.x.
46. Angulo A, Chandraratna RA, LeBlanc JF, Ghazal P. 1998. Ligand induction of retinoic acid receptors alters an acute infection by murine cytomegalovirus. J Virol 72:4589-4600.
47. Kropp KA, Hsieh WY, Isern E, Forster T, Krause E, Brune W, Angulo A, Ghazal P. 2015. A temporal gate for viral enhancers to co-opt Toll-like-receptor transcriptional activation pathways upon acute infection. PLoS Pathog 11:e1004737. http://dx.doi.org/10.1371/journal.ppat.1004737.
48. Manicassamy S, Pulendran B. 2009. Retinoic acid-dependent regulation of immune responses by dendritic cells and macrophages. Semin Immunol 21:22-27. http://dx.doi.org/10.1016/j.smim.2008.07.007.
49. Sinclair J, Reeves M. 2014. The intimate relationship between human cytomegalovirus and the dendritic cell lineage. Front Microbiol 5:389. http://dx.doi.org/10.3389/fmicb.2014.00389.
50. Yokota A, Takeuchi H, Maeda N, Ohoka Y, Kato C, Song S-Y, Iwata M. 2009. GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-producing capacity. Int Immunol 21:361-377. http://dx.doi.org/10.1093/intimm/dxp003.
51. Zhu B, Buttrick T, Bassil R, Zhu C, Olah M, Wu C, Xiao S, Orent W, Elyaman W, Khoury SJ. 2013. IL-4 and retinoic acid synergistically induce regulatory dendritic cells expressing Aldh1a2. J Immunol 191:3139-3151.http://dx.doi.org/10.4049/jimmunol.1300329.
52. Reeves MB, Compton T. 2011. Inhibition of inflammatory interleukin-6 activity via extracellular signal-regulated kinase-mitogen-activated protein kinase signaling antagonizes human cytomegalovirus reactivation from dendritic cells. J Virol 85:12750-12758. http://dx.doi.org/10.1128/JVI.05878-11.
53. Hargett D, Shenk TE. 2010. Experimental human cytomegalovirus latency in CD14+ monocytes. Proc Natl Acad Sci U S A 107:20039-20044. http://dx.doi.org/10.1073/pnas.1014509107.
54. Kew VG, Yuan J, Meier JL, Reeves M. 2014. Mitogen and stress activated kinases act cooperatively with CREB during induction of human cytomegalovirus immediate-early gene expression from latency. PLoS Pathog 10: e10004195.
55. Canon E, Cosgaya JM, Scsucova S, Aranda A. 2004. Rapid effects of retinoic acid on CREB and ERK phosphorylation in neuronal cells. Mol Cell Biol 15:5583-5592. http://dx.doi.org/10.1091/mbc.E04-05-0439.
56. Zassadowski F, Rochette-Egly C, Chomienne C, Cassinat B. 2012. Regulation of the transcriptional activity of nuclear receptors by the MEK/ERK1/2 pathway. Cell Signal 24:2369-2377. http://dx.doi.org/10.1016/j.cellsig.2012.08.003.
57. Taylor-Wiedeman JA, Sissons JGP, Sinclair JH. 1994. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol 68:1597-1604.
58. Soderberg-Naucler C, Streblow DN, Fish KN, Allan-Yorke J, Smith PP, Nelson JA. 2001. Reactivation of latent human cytomegalovirus in CD14+ monocytes is differentiation dependent. J Virol 75:7543-7554. http://dx.doi.org/10.1128/JVI.75.16.7543-7554.2001.
59. Maitra A, Arking DE, Shivapurkar N, Ikeda M, Stastny V, Kassauei K, Sui G, Cutler DJ, Liu Y, Brimble SN, Noaksson K, Hyllner J, Schulz TC, Zeng X, Freed WJ, Crook J, Abraham S, Colman A, Sartipy P, Matsui S, Carpenter M, Gazdar AF, Rao M, Chakravarti A. 2005. Genomic alterations in cultured human embryonic stem cells. Nat Genet 37:1099-1103.http://dx.doi.org/10.1038/ng1631.
60. Gudas LJ. 2013. Retinoids induce stem cell differentiation via epigenetic changes. Semin Cell Dev Biol 24:701-705. http://dx.doi.org/10.1016/j.semcdb.2013.08.002.